‌
‌
Fundamental Analysis:
Ticker
UNCY
Current Price
$1.03 6.19%
Market Cap
$35.8M
Price Target
Refer to Report
Volume
231.1K
52wk Range
$0.47 - $1.8227
Overview
Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead drug candidate, oxylanthanum carbonate (OLC), is a novel investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. UNI-494 is a patent-protected new chemical entity in late preclinical development for the treatment of acute kidney injury. For more information, please visit Unicycive.com and follow us on LinkedIn and YouTube.